Treatment of Cutaneous Leishmaniasis with Thermotherapy in Brazil: an Efficacy and Safety Study

Overview

Journal An Bras Dermatol

Specialty Dermatology

Date 2018 Jun 21

PMID 29924242

Citations 11

Authors

Sheila Viana Castelo Branco Goncalves

Carlos Henrique Nery Costa

Affiliations

Soon will be listed here.

Abstract

Background: Pentavalent antimonials remain as the standard drugs in the treatment of cutaneous leishmaniosis. The high cost, difficult administration, long treatment time, toxicity and increasing morbidity are factors that limit the use of these drugs.

Objectives: To describe the response to radiofrequency thermotherapy in the treatment of localized cutaneous leishmaniasis in Brazil, and to evaluate its safety and tolerability.

Methods: We conducted a non-comparative open trial with a total of 15 patients confirmed to have cutaneous leishmaniasis on parasitological examination. A single radiofrequency thermotherapy session at 50ºC for 30 seconds was applied to the lesion and its edges. In patients with more than one lesion, only the largest one was treated initially. If after 30 days there was no evidence of healing, the smaller lesion was also treated with thermotherapy. Clinical cure was defined as visible healing for three months after treatment. The patients were followed-up for six months and there was no follow-up loss.

Results: Of all 23 lesions, only two evolved to complete healing without the need of treatment. Of 21 lesions, 18 (85.7%) achieved full healing. The main observed side effects were itching, burning sensation, pain and blisters.

Study Limitations: Sample with a small number of patients and short follow-up.

Conclusion: Thermotherapy can be considered a therapeutic alternative in localized cutaneous leishmaniasis, especially in cases of single cutaneous lesions and with formal contraindications to conventional treatment with pentavalent antimonials.

Citing Articles

Meliponini Geopropolis Extracts Induce ROS Production and Death in Promastigotes and Axenic Amastigotes In Vitro.

Sette K, Garcia A, Tinoco L, Pinheiro A, Rodrigues I Biology (Basel). 2025; 14(2).

PMID: 40001930 PMC: 11851448. DOI: 10.3390/biology14020162.

Natural Product Identification and Molecular Docking Studies of Leishmania Major Pteridine Reductase Inhibitors.

Arthur M, Hanson G, Broni E, Sakyi P, Mensah-Brown H, Miller 3rd W Pharmaceuticals (Basel). 2025; 18(1).

PMID: 39861069 PMC: 11768234. DOI: 10.3390/ph18010006.

Heat Waves: A Bibliometric Analysis of Thermotherapy Research.

John Berlin I, Jose J, S R, G P, M N V Cureus. 2024; 16(7):e65700.

PMID: 39211705 PMC: 11361465. DOI: 10.7759/cureus.65700.

Review of Leishmaniasis Treatment: Can We See the Forest through the Trees?.

Shmueli M, Ben-Shimol S Pharmacy (Basel). 2024; 12(1).

PMID: 38392937 PMC: 10892631. DOI: 10.3390/pharmacy12010030.

Potential Effects of Essential Oil from (Mart.) Kausel on : In Vivo, In Vitro, and In Silico Approaches.

Holanda V, Brito T, Oliveira J, Cunha R, Silva A, Silva W Microorganisms. 2024; 12(1).

PMID: 38276192 PMC: 10819817. DOI: 10.3390/microorganisms12010207.

References

Lopez L, Cruz C, Godoy G, Robledo S, Velez I . Thermotherapy effective and safer than miltefosine in the treatment of cutaneous leishmaniasis in Colombia. Rev Inst Med Trop Sao Paulo. 2013; 55(3). DOI: 10.1590/S0036-46652013000300011. View

Reithinger R, Mohsen M, Wahid M, Bismullah M, Quinnell R, Davies C . Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis. 2005; 40(8):1148-55. DOI: 10.1086/428736. View

David C, Craft N . Cutaneous and mucocutaneous leishmaniasis. Dermatol Ther. 2009; 22(6):491-502. DOI: 10.1111/j.1529-8019.2009.01272.x. View

Bumb R, Prasad N, Khandelwal K, Aara N, Mehta R, Ghiya B . Long-term efficacy of single-dose radiofrequency-induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India. Br J Dermatol. 2013; 168(5):1114-9. DOI: 10.1111/bjd.12205. View

Asilian A, Sadeghinia A, Faghihi G, Momeni A . Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis. Int J Dermatol. 2004; 43(4):281-3. DOI: 10.1111/j.1365-4632.2004.02002.x. View

Barbosa A, Sangiorgi B, Galdino S, Barral-Netto M, Pitta I, Pinheiro A . Photodynamic antimicrobial chemotherapy (PACT) using phenothiazine derivatives as photosensitizers against Leishmania braziliensis. Lasers Surg Med. 2012; 44(10):850-5. DOI: 10.1002/lsm.22099. View

Skraba C, Perles de Mello T, Pedroso R, Ferreira E, Demarchi I, Alessi Aristides S . Evaluation of the reference value for the Montenegro skin test. Rev Soc Bras Med Trop. 2015; 48(4):437-44. DOI: 10.1590/0037-8682-0067-2015. View

Hadighi R, Boucher P, Khamesipour A, Meamar A, Roy G, Ouellette M . Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs. Parasitol Res. 2007; 101(5):1319-22. DOI: 10.1007/s00436-007-0638-0. View

Sadeghian G, Nilfroushzadeh M, Iraji F . Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate. Clin Exp Dermatol. 2007; 32(4):371-4. DOI: 10.1111/j.1365-2230.2007.02405.x. View

10.

Almeida O, Santos J . Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review. An Bras Dermatol. 2011; 86(3):497-506. DOI: 10.1590/s0365-05962011000300012. View

11.

Lakhal-Naouar I, Slike B, Aronson N, Marovich M . The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy. PLoS Negl Trop Dis. 2015; 9(10):e0004178. PMC: 4618688. DOI: 10.1371/journal.pntd.0004178. View

12.

Alster T, Tanzi E . Improvement of neck and cheek laxity with a nonablative radiofrequency device: a lifting experience. Dermatol Surg. 2004; 30(4 Pt 1):503-7. DOI: 10.1111/j.1524-4725.2004.30164.x. View

13.

Cardona-Arias J, Dario Velez I, Lopez-Carvajal L . Efficacy of thermotherapy to treat cutaneous leishmaniasis: a meta-analysis of controlled clinical trials. PLoS One. 2015; 10(5):e0122569. PMC: 4444239. DOI: 10.1371/journal.pone.0122569. View

14.

Prasad N, Ghiya B, Bumb R, Kaushal H, Saboskar A, Lezama-Davila C . Heat, Oriental sore, and HIV. Lancet. 2011; 377(9765):610. DOI: 10.1016/S0140-6736(10)61495-X. View

15.

Moreira R, Rebelo J, Gama M, Costa J . [knowledge level about of American tegumentary leishmaniasis (ATL) and use of alternative therapies in an endemic area in the Amazon Region in the State of Maranhão, Brazil]. Cad Saude Publica. 2002; 18(1):187-95. DOI: 10.1590/s0102-311x2002000100019. View

16.

Navin T, Arana B, Arana F, De Merida A, Castillo A, Pozuelos J . Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg. 1990; 42(1):43-50. DOI: 10.4269/ajtmh.1990.42.43. View

17.

Lopez L, Robayo M, Vargas M, Velez I . Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis. Trials. 2012; 13:58. PMC: 3441257. DOI: 10.1186/1745-6215-13-58. View

18.

Paula C, Sampaio J, Cardoso D, Sampaio R . [A comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20mgSbV/day for 20 days to treat cutaneous leishmaniasis]. Rev Soc Bras Med Trop. 2003; 36(3):365-71. View

19.

Sacks D, Barral A, NEVA F . Thermosensitivity patterns of Old vs. New World cutaneous strains of Leishmania growing within mouse peritoneal macrophages in vitro. Am J Trop Med Hyg. 1983; 32(2):300-4. DOI: 10.4269/ajtmh.1983.32.300. View

20.

Goto H, Lindoso J . Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther. 2010; 8(4):419-33. DOI: 10.1586/eri.10.19. View